Tag Archives: Patent Law

Allergan V. Sandoz – When Everything “Old” Is “New” Again

Posted on May 2, 2013 by Warren Woessner

On Tuesday, a divided panel of the Fed. Cir. found that Allergan’s claimed method of reducing the number of daily topical doses of brimonidine to treat glaucoma from 3 to 2 doses by administering a composition containing 0.2% brimonidine and … Continue reading →

Posted in Inherency | Tagged Allergan v Sandoz, biotechnology, biotechnology law, Federal Circuit, intellectual property, ip, Patent Law, patents, Warren Woessner | Leave a comment

Myriad Argued Before The Supreme Court – Some Snippets

Posted on April 17, 2013 by Warren Woessner

I confess that I’ve become addicted to this case and just finished all 63 pages of the transcript of the oral argument that took place on Monday. I won’t try to summarize it, but rather will try to review some … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged DNA, Myriad, Oral Arguments, Patent Law, Supreme Court, Warren Woessner | Leave a comment

Saffran v. J&J – When Defining Equals Disclaiming

Posted on April 17, 2013 by Warren Woessner

A guest post from Theresa Stadheim of Schwegman Lundberg & Woessner, P.A. In Bruce N. Saffran, M.D., Ph.D., v. Johnson & Johnson and Cordis Corporation, Appeal No. 2012-1043 (Fed. Cir. April 4, 2013, decision by Lourie), the Federal Circuit reversed … Continue reading →